Clinical Trial Update: Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure [NA]

View source ↗

Summary

A completed trial comparing imipenem-cilastatin versus cefepime for spontaneous bacterial peritonitis and evaluating risk factors for treatment failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Cefepime (cefepime)
• Imipenem/Cilastatin (imipenem/cilastatin)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Spontaneous Bacterial Peritonitis | NA | Status: COMPLETED